Sage Therapeutics is about to begin Phase II testing of Sage-324 for Essential Tremor. There is a lot to learn about the way Sage is thinking about Neurological Disorders on their corporate website at:
- https://www.sagerx.com/programs-research/neurologic-disorders/
- https://www.sagerx.com/programs-research/pipeline/
- https://investor.sagerx.com/news-releases/news-release-details/sage-therapeutics-announces-clinical-updates-and-progress-across
